Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 15.29 M447 K938.48 K1.75 M1.36 M 4.49 M Research & development 263.09 K352.89 K207.9 K100.04 K296.72 K 957.54 K Operating income -15.56 M-799.89 K-1.15 M-1.85 M-1.65 M -5.44 M Non-Operating Income, Total -384.85 K-1.18 M-705 K-2.86 M-1.58 M -6.32 M Interest expense, net of interest capitalized 289.93 K527.89 K1.48 M6.23 M0 8.24 M Non-Operating Income, excl. Interest Expenses -384.85 K-1.18 M-705 K-2.86 M-1.58 M -6.32 M Unusual income/expense ————— — Pretax income -16.23 M-3.24 M-3.33 M-10.94 M-3.22 M -20.73 M Equity in earnings ————— — Taxes ——000 — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -15.94 M-1.98 M-1.85 M-4.71 M-3.22 M -11.76 M Discontinued operations ————— — Net income -15.94 M-1.98 M-1.85 M-4.71 M-3.22 M -11.76 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -15.94 M-1.98 M-1.85 M-4.71 M-3.22 M -11.76 M Basic earnings per share (Basic EPS) 50436.88-48—-20.57 — Diluted earnings per share (Diluted EPS) 50436.88-4824.6-20.57 -7.09 Average basic shares outstanding 31.58 K-72.85 K41.27 K49.83 K156.69 K — Diluted shares outstanding 31.58 K-72.85 K41.27 K49.83 K156.69 K — EBITDA ——-142.34 K4.07 M-62.28 K — EBIT -15.56 M-1.16 M-1.15 M-1.85 M-1.65 M -5.81 M Cost of revenue ——1 0575 26122.6 K — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ——1 M5.92 M1.58 M —